Addex Therapeutics Ltd - ADR
ADXN
Market Cap$8.38M
Close$
$-0.11
101.3% downside
Current Fair Value
101.3% downsideOvervalued by 101.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.38 Million |
|---|---|
| Enterprise Value | $5.15 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-16.8 |
| Beta | 1.99 |
| Outstanding Shares | 812,788 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.84 |
|---|---|
| PEG | -2.03 |
| Price to Sales | - |
| Price to Book Ratio | 0.66 |
| Enterprise Value to Revenue | 9.24 |
| Enterprise Value to EBIT | -0.8 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Addex Therapeutics Ltd
27 employees
CEO: Tim Dyer